Health10 hours ago
Alzinova’s ALZ-101 Vaccine Enters Phase II Trials for Alzheimer’s
The Swedish biopharmaceutical company Alzinova has received approval from the U.S. Food and Drug Administration (FDA) to advance its Alzheimer’s vaccine candidate, ALZ-101, into a Phase...